from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A humanized monoclonal antibody used in the treatment of multiple sclerosis and Crohn's disease.


Ad hoc prefix + -li- + -zu- + -mab (Wiktionary)


  • Also known as natalizumab, Tysabri showed great promise in early trials; it reduced the frequency of relapses by 66 percent and looked to be twice as effective as alternatives in preventing flare-ups of the disease over a year’s time, representing a significant improvement over other MS therapies.

    The Autoimmune Epidemic

  • Elan's breakthrough selective adhesion molecule inhibitor Tysabri® natalizumab is approved for the treatment multiple sclerosis and Crohn's disease.

    Xoma and Elan: A Tale of Two Mismanaged Biotech Companies, Part 2 - Seeking Alpha

  • Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sc ...


  • Accutane Side Effects Years After Stopping que amazed phar toda la dosis, depigmentation un declaration de natalizumab tourettes chlorphenesin vaso, zyrtecabatacept suavemente y stomache de inmediato.


  • Earlier work by Steinman, proceeding from animal models to clinical trials, led to the development of another blockbuster multiple-sclerosis drug, natalizumab, marketed under the trade name Tysabri.


  • However, US FDA believes that the clinical benefits of natalizumab (Tysabri) continue to outweigh the potential risks.

    DWS Full News Feed

  • US FDA notified healthcare professionals and patients that the risk of developing progressive multifocal leukoencephalopathy (PML) increases with the number of natalizumab (Tysabri) infusions received.

    DWS Full News Feed

  • (RRMS) treated with TYSABRI® (natalizumab) and to physicians who prescribe the drug in the

    EurekAlert! - Breaking News

  • U.S. and European physicians strongly associate alemtuzumab with best-in-class efficacy against other disease modifying therapies, including natalizumab and emerging oral options cladribine and fingolimod;

    Genzyme Details Market Potential of Alemtuzumab for MS - Yahoo! Finance

  • Physicians score alemtuzumab significantly higher than natalizumab on measures of safety and efficacy.

    Genzyme Details Market Potential of Alemtuzumab for MS - Yahoo! Finance


Log in or sign up to get involved in the conversation. It's quick and easy.